A BusinessWorld Online piece on Ozempic, a diabetes medicine widely used off label for losing weight. Little detail was available.
Recap by typeshit. Full story at BusinessWorld Online.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
18:51
A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
Users most often reported increased appetite, unlike the stomach issues seen in trials. The authors say it proves nothing causal and only flags leads to test.
Lexaria says some DehydraTECH formulas hit its best absorption yet and filed 3 patents. Semaglutide brain levels were too low to measure in this rat study.
Loading…